XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.1
Note D - Marketable Securities
3 Months Ended
Mar. 31, 2023
Notes to Financial Statements  
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]

D.

Marketable Securities

 

The Company accounts for equity securities under ASC 321. Such securities are reported at fair value on the consolidated balance sheets, and the related unrealized gains and losses are reported in the consolidated statements of cash flows as non-cash adjustments to income. Any realized and unrealized gains or losses on investment securities are reported in the consolidated statements of operations as investment income or (loss).

 

Details of marketable securities held at March 31, 2023 and December 31, 2022 are as follows (in thousands):

 

          

Cumulative

 
          

Unrealized

 
  

Fair Value

  

Basis

  

(Loss) Gain

 
IronNet Securities:     March 31, 2023     

98,750 shares of common stock

 $35  $2,128  $(2,093

)

Equity funds and other securities

  16,852   17,024   (172

)

  $16,887  $19,152  $(2,265

)

 

IronNet Securities:

 

December 31, 2022

 

198,750 shares of common stock

 $46  $4,273  $(4,227

)

Equity funds and other securities

  16,539   17,024   (485

)

  $16,585  $21,297  $(4,712

)

 

 

The shares of IRNT common stock were received by the Company as a result of the previously discussed Sponsor distribution. The fair value of these shares determined at the date of distribution represents the basis of these securities.